Grant: Operating Grant
University of Ottawa
$882,625.00
Mechanism of calpain mediated dopamine loss in PD.
EF 2008-09
Résumé
Parkinsons disease is a progressive neurodegenerative disorder characterized by loss of specialized brain cells which produce the brain molecule dopamine. Loss of these cells results in impaired movement which is one of the significant, although not exclusive, symptoms of the disease. Recent efforts in this field have focused on understanding the regulatory processes which control this type of death. We have recently shown that a specific protease called calpains may participate in this process. The present research is geared towards determining the causal nature of calpains in this process and determining how calpains mediate this degeneration. In understanding these pathways, we hope to, not only gain an appreciation for an important basic biological process, but also devise therapeutic strategies to treat Parkinsons disease.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
170677
Name
Park David S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Molecular & Cellular Neurosciences - B
Projecttitle
Mechanism of calpain mediated dopamine loss in PD.
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$882,625
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Calpains; Cdk5; Dna Damage; Dopamine; Neuronal Death; Parkinsons Disease; Substantia Nigra
Abstract
Parkinsons disease is a progressive neurodegenerative disorder characterized by loss of specialized brain cells which produce the brain molecule dopamine. Loss of these cells results in impaired movement which is one of the significant, although not exclusive, symptoms of the disease. Recent efforts in this field have focused on understanding the regulatory processes which control this type of death. We have recently shown that a specific protease called calpains may participate in this process. The present research is geared towards determining the causal nature of calpains in this process and determining how calpains mediate this degeneration. In understanding these pathways, we hope to, not only gain an appreciation for an important basic biological process, but also devise therapeutic strategies to treat Parkinsons disease.
Competitiondate
200809
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Park, David S
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $882,625~ $0~